RNAi技術の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global RNAi Technologies Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-16565 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、108ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥494,160 (USD3,480)	▷ お問い合わせ
Multi User	￥741,240 (USD5,220)	▷ お問い合わせ
Corporate User	￥988,320 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、RNAi技術の世界市場を広く調査・分析し、今後の市場展望をまとめております。RNAi技術の種類別市場規模（腫瘍、眼疾患、呼吸器疾患、肝疾患、その他）、用途別市場規模（研究、治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Alnylam Pharmaceuticals、Invitrogen、Ionis Pharmaceuticals、Benitec Biopharma Ltd、Qiagen、Filmtec Corporation、RXI Pharmaceuticals、Quark Pharmaceuticals Inc.、Ambion ・地域別グローバル市場分析 2015年-2020年 ・RNAi技術の北米市場（アメリカ、カナダ、メキシコ） ・RNAi技術のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・RNAi技術のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・RNAi技術の南米市場（ブラジル、アルゼンチン） ・RNAi技術の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：腫瘍、眼疾患、呼吸器疾患、肝疾患、その他 ・用途別分析：研究、治療 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global RNAi Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 363.3 million by 2025, from USD 303.9 million in 2019.

The RNAi Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
RNAi Technologies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, RNAi Technologies market has been segmented into:
Oncology
Ocular disorders
Respiratory disorders
Liver diseases
Other

By Application, RNAi Technologies has been segmented into:
Research
Therapeutics

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global RNAi Technologies market presented in the report. This section sheds light on the sales growth of different regional and country-level RNAi Technologies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global RNAi Technologies market.

The report offers in-depth assessment of the growth and other aspects of the RNAi Technologies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and RNAi Technologies Market Share Analysis
RNAi Technologies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, RNAi Technologies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the RNAi Technologies sales, revenue and market share for each player covered in this report.

The major players covered in RNAi Technologies are:
Alnylam Pharmaceuticals
Invitrogen
Ionis Pharmaceuticals
Benitec Biopharma Ltd
Qiagen
Filmtec Corporation
RXI Pharmaceuticals
Quark Pharmaceuticals Inc.
Ambion

レポート目次

---

Table of Contents

1 RNAi Technologies Market Overview
1.1 Product Overview and Scope of RNAi Technologies
1.2 Classification of RNAi Technologies by Type
1.2.1 Global RNAi Technologies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global RNAi Technologies Revenue Market Share by Type in 2019
1.2.3 Oncology
1.2.4 Ocular disorders
1.2.5 Respiratory disorders
1.2.6 Liver diseases
1.2.7 Other
1.3 Global RNAi Technologies Market by Application
1.3.1 Overview: Global RNAi Technologies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Research
1.3.3 Therapeutics
1.4 Global RNAi Technologies Market by Regions
1.4.1 Global RNAi Technologies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of RNAi Technologies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) RNAi Technologies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) RNAi Technologies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RNAi Technologies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) RNAi Technologies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RNAi Technologies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Alnylam Pharmaceuticals
2.1.1 Alnylam Pharmaceuticals Details
2.1.2 Alnylam Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alnylam Pharmaceuticals SWOT Analysis
2.1.4 Alnylam Pharmaceuticals Product and Services
2.1.5 Alnylam Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.2 Invitrogen
2.2.1 Invitrogen Details
2.2.2 Invitrogen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Invitrogen SWOT Analysis
2.2.4 Invitrogen Product and Services
2.2.5 Invitrogen RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ionis Pharmaceuticals
2.3.1 Ionis Pharmaceuticals Details
2.3.2 Ionis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ionis Pharmaceuticals SWOT Analysis
2.3.4 Ionis Pharmaceuticals Product and Services
2.3.5 Ionis Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Benitec Biopharma Ltd
2.4.1 Benitec Biopharma Ltd Details
2.4.2 Benitec Biopharma Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Benitec Biopharma Ltd SWOT Analysis
2.4.4 Benitec Biopharma Ltd Product and Services
2.4.5 Benitec Biopharma Ltd RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.5 Qiagen
2.5.1 Qiagen Details
2.5.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Qiagen SWOT Analysis
2.5.4 Qiagen Product and Services
2.5.5 Qiagen RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Filmtec Corporation
2.6.1 Filmtec Corporation Details
2.6.2 Filmtec Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Filmtec Corporation SWOT Analysis
2.6.4 Filmtec Corporation Product and Services
2.6.5 Filmtec Corporation RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.7 RXI Pharmaceuticals
2.7.1 RXI Pharmaceuticals Details
2.7.2 RXI Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 RXI Pharmaceuticals SWOT Analysis
2.7.4 RXI Pharmaceuticals Product and Services
2.7.5 RXI Pharmaceuticals RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.8 Quark Pharmaceuticals Inc.
2.8.1 Quark Pharmaceuticals Inc. Details
2.8.2 Quark Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Quark Pharmaceuticals Inc. SWOT Analysis
2.8.4 Quark Pharmaceuticals Inc. Product and Services
2.8.5 Quark Pharmaceuticals Inc. RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.9 Ambion
2.9.1 Ambion Details
2.9.2 Ambion Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Ambion SWOT Analysis
2.9.4 Ambion Product and Services
2.9.5 Ambion RNAi Technologies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global RNAi Technologies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 RNAi Technologies Players Market Share
3.2.2 Top 10 RNAi Technologies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global RNAi Technologies Revenue and Market Share by Regions
4.2 North America RNAi Technologies Revenue and Growth Rate (2015-2020)
4.3 Europe RNAi Technologies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific RNAi Technologies Revenue and Growth Rate (2015-2020)
4.5 South America RNAi Technologies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa RNAi Technologies Revenue and Growth Rate (2015-2020)
5 North America RNAi Technologies Revenue by Countries
5.1 North America RNAi Technologies Revenue by Countries (2015-2020)
5.2 USA RNAi Technologies Revenue and Growth Rate (2015-2020)
5.3 Canada RNAi Technologies Revenue and Growth Rate (2015-2020)
5.4 Mexico RNAi Technologies Revenue and Growth Rate (2015-2020)
6 Europe RNAi Technologies Revenue by Countries
6.1 Europe RNAi Technologies Revenue by Countries (2015-2020)
6.2 Germany RNAi Technologies Revenue and Growth Rate (2015-2020)
6.3 UK RNAi Technologies Revenue and Growth Rate (2015-2020)
6.4 France RNAi Technologies Revenue and Growth Rate (2015-2020)
6.5 Russia RNAi Technologies Revenue and Growth Rate (2015-2020)
6.6 Italy RNAi Technologies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific RNAi Technologies Revenue by Countries
7.1 Asia-Pacific RNAi Technologies Revenue by Countries (2015-2020)
7.2 China RNAi Technologies Revenue and Growth Rate (2015-2020)
7.3 Japan RNAi Technologies Revenue and Growth Rate (2015-2020)
7.4 Korea RNAi Technologies Revenue and Growth Rate (2015-2020)
7.5 India RNAi Technologies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia RNAi Technologies Revenue and Growth Rate (2015-2020)
8 South America RNAi Technologies Revenue by Countries
8.1 South America RNAi Technologies Revenue by Countries (2015-2020)
8.2 Brazil RNAi Technologies Revenue and Growth Rate (2015-2020)
8.3 Argentina RNAi Technologies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue RNAi Technologies by Countries
9.1 Middle East & Africa RNAi Technologies Revenue by Countries (2015-2020)
9.2 Saudi Arabia RNAi Technologies Revenue and Growth Rate (2015-2020)
9.3 UAE RNAi Technologies Revenue and Growth Rate (2015-2020)
9.4 Egypt RNAi Technologies Revenue and Growth Rate (2015-2020)
9.5 South Africa RNAi Technologies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global RNAi Technologies Revenue and Market Share by Type (2015-2020)
10.2 Global RNAi Technologies Market Forecast by Type (2019-2024)
10.3 Oncology Revenue Growth Rate (2015-2025)
10.4 Ocular disorders Revenue Growth Rate (2015-2025)
10.5 Respiratory disorders Revenue Growth Rate (2015-2025)
10.6 Liver diseases Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global RNAi Technologies Market Segment by Application
11.1 Global RNAi Technologies Revenue Market Share by Application (2015-2020)
11.2 RNAi Technologies Market Forecast by Application (2019-2024)
11.3 Research Revenue Growth (2015-2020)
11.4 Therapeutics Revenue Growth (2015-2020)
12 Global RNAi Technologies Market Size Forecast (2021-2025)
12.1 Global RNAi Technologies Market Size Forecast (2021-2025)
12.2 Global RNAi Technologies Market Forecast by Regions (2021-2025)
12.3 North America RNAi Technologies Revenue Market Forecast (2021-2025)
12.4 Europe RNAi Technologies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific RNAi Technologies Revenue Market Forecast (2021-2025)
12.6 South America RNAi Technologies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa RNAi Technologies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global RNAi Technologies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of RNAi Technologies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global RNAi Technologies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market RNAi Technologies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Alnylam Pharmaceuticals Corporate Information, Location and Competitors
Table 6. Alnylam Pharmaceuticals RNAi Technologies Major Business
Table 7. Alnylam Pharmaceuticals RNAi Technologies Total Revenue (USD Million) (2017-2018)
Table 8. Alnylam Pharmaceuticals SWOT Analysis
Table 9. Alnylam Pharmaceuticals RNAi Technologies Product and Solutions
Table 10. Alnylam Pharmaceuticals RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Invitrogen Corporate Information, Location and Competitors
Table 12. Invitrogen RNAi Technologies Major Business
Table 13. Invitrogen RNAi Technologies Total Revenue (USD Million) (2018-2019)
Table 14. Invitrogen SWOT Analysis
Table 15. Invitrogen RNAi Technologies Product and Solutions
Table 16. Invitrogen RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Ionis Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Ionis Pharmaceuticals RNAi Technologies Major Business
Table 19. Ionis Pharmaceuticals RNAi Technologies Total Revenue (USD Million) (2017-2018)
Table 20. Ionis Pharmaceuticals SWOT Analysis
Table 21. Ionis Pharmaceuticals RNAi Technologies Product and Solutions
Table 22. Ionis Pharmaceuticals RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Benitec Biopharma Ltd Corporate Information, Location and Competitors
Table 24. Benitec Biopharma Ltd RNAi Technologies Major Business
Table 25. Benitec Biopharma Ltd RNAi Technologies Total Revenue (USD Million) (2017-2018)
Table 26. Benitec Biopharma Ltd SWOT Analysis
Table 27. Benitec Biopharma Ltd RNAi Technologies Product and Solutions
Table 28. Benitec Biopharma Ltd RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Qiagen Corporate Information, Location and Competitors
Table 30. Qiagen RNAi Technologies Major Business
Table 31. Qiagen RNAi Technologies Total Revenue (USD Million) (2017-2018)
Table 32. Qiagen SWOT Analysis
Table 33. Qiagen RNAi Technologies Product and Solutions
Table 34. Qiagen RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Filmtec Corporation Corporate Information, Location and Competitors
Table 36. Filmtec Corporation RNAi Technologies Major Business
Table 37. Filmtec Corporation RNAi Technologies Total Revenue (USD Million) (2017-2018)
Table 38. Filmtec Corporation SWOT Analysis
Table 39. Filmtec Corporation RNAi Technologies Product and Solutions
Table 40. Filmtec Corporation RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. RXI Pharmaceuticals Corporate Information, Location and Competitors
Table 42. RXI Pharmaceuticals RNAi Technologies Major Business
Table 43. RXI Pharmaceuticals RNAi Technologies Total Revenue (USD Million) (2017-2018)
Table 44. RXI Pharmaceuticals SWOT Analysis
Table 45. RXI Pharmaceuticals RNAi Technologies Product and Solutions
Table 46. RXI Pharmaceuticals RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Quark Pharmaceuticals Inc. Corporate Information, Location and Competitors
Table 48. Quark Pharmaceuticals Inc. RNAi Technologies Major Business
Table 49. Quark Pharmaceuticals Inc. RNAi Technologies Total Revenue (USD Million) (2017-2018)
Table 50. Quark Pharmaceuticals Inc. SWOT Analysis
Table 51. Quark Pharmaceuticals Inc. RNAi Technologies Product and Solutions
Table 52. Quark Pharmaceuticals Inc. RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Ambion Corporate Information, Location and Competitors
Table 54. Ambion RNAi Technologies Major Business
Table 55. Ambion RNAi Technologies Total Revenue (USD Million) (2017-2018)
Table 56. Ambion SWOT Analysis
Table 57. Ambion RNAi Technologies Product and Solutions
Table 58. Ambion RNAi Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global RNAi Technologies Revenue (Million USD) by Players (2015-2020)
Table 60. Global RNAi Technologies Revenue Share by Players (2015-2020)
Table 61. Global RNAi Technologies Revenue (Million USD) by Regions (2015-2020)
Table 62. Global RNAi Technologies Revenue Market Share by Regions (2015-2020)
Table 63. North America RNAi Technologies Revenue by Countries (2015-2020)
Table 64. North America RNAi Technologies Revenue Market Share by Countries (2015-2020)
Table 65. Europe RNAi Technologies Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific RNAi Technologies Revenue (Million USD) by Countries (2015-2020)
Table 67. South America RNAi Technologies Revenue by Countries (2015-2020)
Table 68. South America RNAi Technologies Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa RNAi Technologies Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa RNAi Technologies Revenue Market Share by Countries (2015-2020)
Table 71. Global RNAi Technologies Revenue (Million USD) by Type (2015-2020)
Table 72. Global RNAi Technologies Revenue Share by Type (2015-2020)
Table 73. Global RNAi Technologies Revenue Forecast by Type (2021-2025)
Table 74. Global RNAi Technologies Revenue by Application (2015-2020)
Table 75. Global RNAi Technologies Revenue Share by Application (2015-2020)
Table 76. Global RNAi Technologies Revenue Forecast by Application (2021-2025)
Table 77. Global RNAi Technologies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. RNAi Technologies Picture
Figure 2. Global RNAi Technologies Revenue Market Share by Type in 2019
Figure 3. Oncology Picture
Figure 4. Ocular disorders Picture
Figure 5. Respiratory disorders Picture
Figure 6. Liver diseases Picture
Figure 7. Other Picture
Figure 8. RNAi Technologies Revenue Market Share by Application in 2019
Figure 9. Research Picture
Figure 10. Therapeutics Picture
Figure 11. Global RNAi Technologies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America RNAi Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe RNAi Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific RNAi Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America RNAi Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa RNAi Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global RNAi Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global RNAi Technologies Revenue Share by Players in 2019
Figure 19. Global Top 5 Players RNAi Technologies Revenue Market Share in 2019
Figure 20. Global Top 10 Players RNAi Technologies Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global RNAi Technologies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global RNAi Technologies Revenue Market Share by Regions (2015-2020)
Figure 24. Global RNAi Technologies Revenue Market Share by Regions in 2018
Figure 25. North America RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 26. Europe RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 28. South America RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 30. North America RNAi Technologies Revenue Market Share by Countries (2015-2020)
Figure 31. North America RNAi Technologies Revenue Market Share by Countries in 2019
Figure 32. USA RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 33. Canada RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 34. Mexico RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 35. Europe RNAi Technologies Revenue Market Share by Countries (2015-2020)
Figure 36. Europe RNAi Technologies Revenue Market Share by Countries in 2019
Figure 37. Germany RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 38. UK RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 39. France RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 40. Russia RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 41. Italy RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific RNAi Technologies Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific RNAi Technologies Revenue Market Share by Countries in 2019
Figure 44. China RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 45. Japan RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 46. Korea RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 47. India RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 49. South America RNAi Technologies Revenue Market Share by Countries (2015-2020)
Figure 50. South America RNAi Technologies Revenue Market Share by Countries in 2019
Figure 51. Brazil RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 52. Argentina RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa RNAi Technologies Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa RNAi Technologies Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 56. UAE RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 57. Egypt RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 58. South Africa RNAi Technologies Revenue and Growth Rate (2015-2020)
Figure 59. Global RNAi Technologies Revenue Share by Type (2015-2020)
Figure 60. Global RNAi Technologies Revenue Share by Type in 2019
Figure 61. Global RNAi Technologies Market Share Forecast by Type (2021-2025)
Figure 62. Global Oncology Revenue Growth Rate (2015-2020)
Figure 63. Global Ocular disorders Revenue Growth Rate (2015-2020)
Figure 64. Global Respiratory disorders Revenue Growth Rate (2015-2020)
Figure 65. Global Liver diseases Revenue Growth Rate (2015-2020)
Figure 66. Global Other Revenue Growth Rate (2015-2020)
Figure 67. Global RNAi Technologies Revenue Share by Application (2015-2020)
Figure 68. Global RNAi Technologies Revenue Share by Application in 2019
Figure 69. Global RNAi Technologies Market Share Forecast by Application (2021-2025)
Figure 70. Global Research Revenue Growth Rate (2015-2020)
Figure 71. Global Therapeutics Revenue Growth Rate (2015-2020)
Figure 72. Global RNAi Technologies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global RNAi Technologies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global RNAi Technologies Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America RNAi Technologies Revenue Market Forecast (2021-2025)
Figure 76. Europe RNAi Technologies Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific RNAi Technologies Revenue Market Forecast (2021-2025)
Figure 78. South America RNAi Technologies Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa RNAi Technologies Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---